References
- Green D, Lechner K. A survey of 215 non-hemophilic patients with inhibitors to factor VIII. Thromb Haemost 1981; 45: 200–203
- Bossi P, Cabane J, Ninet J, Dhote R, Hanslik T, Chosidow O, et al. Acquired hemophilia due to factor VIII inhibitors in 34 patients. Am J Med 1998; 105: 400–408
- Kesley P R, Leyland M J. Acquired inhibitor to human factor VIII associated with paraproteinemia and subsequent development of chronic lymphocytic leukemia. Br Med J 1982; 285: 174–176
- Mateo J, Martino R, Borrell M, Gari M, Casas F, Fontcuberta J. Acquired factor VIII inhibitor preceding chronic lymphocytic leukemia. Ann Hematol 1993; 67: 309–311
- Schwartz R S, Gabriel D A, Aledort L M, Green D, Kessler C M. A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose intravenous gammaglobulin. Blood 1995; 86: 797–804
- Ceballos P, Yeche S, Reynaud D, Mouliade C, Dubois A. Inhibiteur acquis du factor VIII et leucemie lymphoide chronique:a propos d'un cas. Rev Med Interne 1996; 17: 150–153
- DiBona E, Schiavoni M, Castaman G, Ciavarella N, Rodeghiero F. Acquired hemophilia: experience of two Italian centers with 17 new cases. Haemophilia 1997; 3: 183–188
- Ghirarduzzi A, Silingardi M, D'Inca M, Tincani E. Sindrome da anticorpi antifosfolipida in corso di leukemia linfatica cronica. Associazione con autoanticorpi anti-fattore VIII. Ann Ital Med Int 1999; 14: 46–50
- Blanche P, Bouscary D, Gombert B, Stieltjes N, Dreyfus F, Sicard D. Successful treatment of acquired factor VIII inhibitor with fludrarabine and cyclophosphamide in chronic lymphoid leukemia. Leukemia 1999; 13: 1294
- Sallah S, Nguyen N P, Abdallah J M, Hanrahan L R. Acquired hemophilia in patients with hematologic malignancies. Arch Pathol Lab Med 2000; 124: 730–734
- Hall R L, Leahy M F. Acquired factor VIII autoantobody: four cases demonstrating the heterogenous nature of this condition and problems involved in diagnosis and treatment. Eur J Haematol 2001; 66: 206–209
- Diehl L F, Ketchum L H. Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia. Semin Oncol 1998; 25: 80–97
- Kyasa M J, Parrish R S, Schichman S A, Zent C S. Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma. Am J Hematol 2003; 74: 1–8
- Goodrick M J, Prentice A G, Copplestone J A, Pamphilon D H, Boon R J. Acquired factor XI inhibitor in chronic lymphocytic leukaemia. J Clin Pathol 1992; 45: 352–353
- Zeitler H, Ulrich-Merzenich G, Hess L, Konsek E, Unkrig C, Walger P, et al. Treatment of acquired hemophilia by the Bonn-Malmo Protocol: documentation of an in vivo immunomodulating concept. Blood 2005; 105: 2287–2293
- Longo G, Luppi M, Ferrara L, Torelli U, Barbieri U, Torelli G. Acquired factor VIII inhibitor at the onset of prolymphocytic leukemia. Leukemia 1996; 10: 1557–1558
- Hay C R, Brown S, Collins P W, Keeling D M, Liesner R. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation. Br J Haematol 2006; 133: 591–605
- D'Arena G, Laurenti L, Capalbo S, D'Arco A M, De Filippi R, Marcacci G, et al. Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia. Am J Hematol 2006; 81: 598–602
- Wiestner A, Cho H J, Asch A S, Michelis M A, Zeller J A, Peerschke E I, et al. Rituximab in the treatment of acquired factor VIII inhibitors. Blood 2002; 101: 3426–3428